¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-03
±³À°ÀÏÀÚ : 2021-09-03
±³À°Àå¼Ò : ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ì¿ï.Á¶¿ïº´ÇÐȸ (ÀÌ»çÀåÁ¦)  
´ã´çÀÚ : ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-3779-1250  
À̸ÞÀÏ : webmaster@thekasad.or.kr      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 90¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 13 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï: Á¤È¸¿ø 5¸¸¿ø, ÁØȸ¿ø 3¸¸¿ø, ºñȸ¿ø 6¸¸¿ø, Æò»ýȸ¿ø ¸éÁ¦ ´çÀϵî·Ï: Á¤È¸¿ø 6¸¸¿ø, ÁØȸ¿ø 4¸¸¿ø, ºñȸ¿ø 8¸¸¿ø, Æò»ýȸ¿ø 1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 09:30~09:50 Mood and personal traits as risk factors for physical illness  È«Á¤¿Ï(Àͻ꺴¿ø) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 09:50~10:10 Inflammation, physical illness, and depression  ½Å»óÈ£(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 10:10~10:40 Metabolic syndrome and bipolar disorder  °­¿ø¼·(°æÈñÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 10:55~11:15 Antidepressants: Minimalist vs. maximalist view  ¹Ú¼º¿ë(°è¿äº´¿ø) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 11:15~11:35 Antipsychotics: Evidence based treatment vs. potential treatment  ¹Ú¿µ¹Î(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 11:35~12:05 Augmentation therapy: Focus on dopamine agonist & stimulant  Á¤¸íÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 12:05~12:35 Anxiety & depression in the COVID pandemia  ¿ì¿µ¼·(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 12:35~13:05 Benefits of Agomelatine treatment strategies  Á¤Á¾Çö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 13:20~13:35 ¡®Irritability¡¯ as a symptom of depression for children and adolescents?  À̹®¼ö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 13:35~13:50 What can tell the differences between bipolar disorder and ADHD?  ½É¼¼ÈÆ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 13:50~14:05 Are there cognitive dysfunctions in bipolar disorder?  ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 14:05~14:30 What is the vascular depression hypothesis?  ÀÌ°­¼ö(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 14:30~14:50 Major depressive disorder  ¿ì¿µ¼·(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 14:50~15:10 Bipolar disorder: Manic episode and mixed features  ¹®Àº¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 15:10~15:40 Bipolar disorder: Depressive episode  ÀÓÀº¼º(½Å¼¼°èÈ¿º´¿ø) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 15:50~16:10 Navigating the world of ADHD medications  ¾çÂù¸ð(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 16:10~16:30 Diagnosing and treating major depressive episodes with mixed features  ½ÉÀÎÈñ(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 16:30~17:00 Long-acting injectable antipsychotics in bipolar disorder  ±è°æ¹Î(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ09:30~09:50 Suicide rate and risk factors in pandemic  °­ÇÑ°íÀººñ(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ09:50~10:10 Immunity, suicide and COVID-19: A linking pathway  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ10:10~10:40 Suicide prevention during COVID-19  ¿ÀÈ«¼®(°Ç¾çÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ10:55~11:55 Mindfulness-based interventions for depression  ±¸º»ÈÆ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ12:05~12:35 Importance of multifactorial condition management  ¼ºÇü¸ð(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ12:35~13:05 Successful management of patient adherence  ³²¹ü¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ13:20~13:40 Glutamatergic system  ¼Û¹Î±Ô(¼º¸ð°ø°¨Á¤½Å°Ç°­ÀÇÇаúÀÇ¿ø) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ13:40~14:00 GABAergic system  ±èÅÂÈñ(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ14:00~14:30 Inflammatory system  ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ14:30~15:00 Overview and CBT approaches  ±è¿ø(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ15:00~15:30 Family interventions  Á¤¿µÀº(Á¦ÁÖÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ15:50~16:10 PTSD and depression after trauma exposure  À̺´Ã¶(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ16:10~16:30 Biological underpinnings of trauma and depression  ±èÁö¼±(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ16:30~17:00 Treating depression of victims  ±è¿øÇü(ÀÎÇÏÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѺñ¸¸ÇÐȸ ICOMES 2021 (2ÀÏÂ÷) : 2021-09-03
´ÙÀ½±Û ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ (¿Â¶óÀÎ) International Colorectal Research Summit 2021-Precongress (1ÀÏÂ÷) : 2021-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 11 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 14 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 12 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 11 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 11 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 17 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 7 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 18 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 9 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 15 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 9 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 8 2024-05-27
20775 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 1±â(1ÀÏÂ÷) : 2024-06-13 0 18 2024-05-27
20774 ºÎ»ê (¿Â¶óÀÎ) ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³² ÁöºÎȸ 2024³â 06¿ù Çмú´ëȸ : 2024-06-13 0 11 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷